Pharma Marketing Network

APRIL 10, 2025

Table of Contents Why PPC Campaigns Work for Pharma Strategic Audience Targeting and Keyword Planning Compliance, Creativity, and Conversion Optimization Measuring Success: Metrics That Matter Why PPC Campaigns Work for Pharma PPC campaigns deliver ads to users actively searching for health-related topics, treatments, or branded medications.

Marketing 52

Marketing Branding Compliance Pharma Companies 52

Find Me Cure

SEPTEMBER 2, 2020

This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. . Today let’s take a look at some of the barriers to trial participation and the issues that break the trust patients have in research. .

Clinical Research 97

Clinical Research Research Clinical Trials Clinical Trials 97

pharmaphorum

DECEMBER 15, 2021

Dialogue requires humility on the drug company’s side—accepting that sometimes we are wrong about matters we think we understand—and trust on the patients’ side that representatives of large, for-profit entities really have come to listen.

Pharma Companies 145

Pharma Companies Development Medicine Drugs 145

pharmaphorum

OCTOBER 11, 2022

So, historically – certainly pre-2000 – if you look at the way prescription drugs were communicated, it was very tightly controlled: it was pharma companies speaking to doctors and the doctor would speak to the patient and tell them what they thought the right solution was,” he said.

Medicine 98

Medicine Pharma Companies Doctor Doctors 98

pharmaphorum

JANUARY 24, 2022

That is backed up by a meta analysis of its performance published last year in Nature found that the treatment recommendations delivered by the tool were largely in line with human doctors for several cancer types.

Radiology 111

Radiology Marketing Genomics Genome 111

pharmaphorum

DECEMBER 24, 2020

If you, or someone you know, has had to see a doctor since March, the chances are the health service tried to avoid an in-person visit to limit the spread of the coronavirus. Telehealth reached a tipping point. The rapid digitalisation of life during COVID-19’s acute phase also had a huge impact on healthcare delivery. About the author.

Pharma Companies 126

Pharma Companies Clinical Trials Clinical Trials Doctor 126

Pharmaceutical Technology

NOVEMBER 2, 2022

But educating the world of physicians about these new medicines and collaborating with healthcare professionals on trials and other important initiatives is critical to their commercial success. Nowadays, it is an active choice many pharma companies and service providers are taking. Participant management can also be a problem.

Medicine 130

Medicine Doctor Doctors Marketing 130

World of DTC Marketing

JUNE 22, 2021

(New York Times ) If you spend any time reading pharma PR releases, you’ll see over and over again corporate managements stressing the importance of the shareholder. When a new drug is derailed the first thing that pops out is the effect on the company’s stock price, not patients.

Drugs 156

Drugs Medicine Pharma Companies Doctor 156

pharmaphorum

SEPTEMBER 28, 2020

Clinical trial readouts continue to emerge despite countries’ lockdown policies, providing several decision-making challenges for healthcare professionals such as haematologists and oncologists – also known as haem/oncs. Challenges for community-based haem/oncs.

Doctor 105

Doctor Doctors Pharma Companies Clinical Trials 105

Placebo Control

MAY 30, 2013

Even by the already-painfully-embarrassingly-low standards of clinical trial enrollment in general, patient enrollment in cancer clinical trials is slow. In many cancer trials, randomizing one patient every three or four months isn't bad at all – in fact, it's par for the course. Horribly slow.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Pharma Companies 40

pharmaphorum

JANUARY 7, 2021

The California-based company has signed a non-exclusive license with Pfizer to supply its 89Zr CD8 Immuno-PET agent, which can be used to image CD8 T cells in cancer patients. Information of this kind can make or break a cancer trial, giving guidance about whether a tumour is growing or has become swollen because of an incursion by T-cells.

Immune Response 53

Immune Response Doctor Doctors Pharma Companies 53

XTalks

AUGUST 21, 2023

The FDA approval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release. Safety and Effectiveness of Sohonos The Phase III MOVE trial evaluated the safety and efficacy of palovarotene in decreasing new HO in participants with FOP.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

pharmaphorum

NOVEMBER 30, 2022

The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas. Facts that they gleaned included: Across Europe, only 52% of HCPs will accept a visit from a pharma company (i.e. Veeva is equally ‘super excited’.

Life Science 98

Life Science Pharma Companies Sales Marketing 98

Cloudbyz

SEPTEMBER 25, 2020

Clinical trials play a pivotal role in drug development. Time is also of the essence in drug development, as competitive product-to-market lead times help pharma companies improve profitability. Time spent on clinical trials involves investment and being able to predict ADRs assists with improving the success rate.

Pharma Companies 52

Pharma Companies Big Data Drugs Clinical Trials 52

Pharma Marketing Network

MARCH 3, 2025

With physicians spending more time online and patients searching for medical information, pharma marketers must refine their digital strategies to create meaningful engagement. Imagine launching a campaign that reaches the right doctor at the right time or helps a patient understand treatment options without feeling overwhelmed.

Compliance 52

Compliance Branding Doctor Doctors 52

Pharma Marketing Network

MARCH 3, 2025

With physicians spending more time online and patients searching for medical information, pharma marketers must refine their digital strategies to create meaningful engagement. Imagine launching a campaign that reaches the right doctor at the right time or helps a patient understand treatment options without feeling overwhelmed.

Compliance 52

Compliance Branding Doctor Doctors 52

pharmaphorum

JANUARY 6, 2021

Analysts are continuing to back Inventiva’s lanifibranor as a potential “best-in-class” drug for the fatty liver disease NASH, as the company prepares for the launch of a phase 3 trial in spring. The trial will take a while however, with results not due until the second half of 2023, with sales forecast to peak at around $2.6

Gene Silencing 52

Gene Silencing Regulation Pharma Companies Trials 52

Pharma Marketing Network

FEBRUARY 5, 2025

With millions of healthcare professionals (HCPs) and patients active on platforms like LinkedIn, Twitter, Facebook, and Instagram, pharma brands can no longer afford to stay silent. Effective social media strategies allow pharma companies to: Build trust with HCPs and patients. Pharma brands can: Join relevant hashtags (e.g.,

Marketing 52

Marketing Branding Compliance Pharma Companies 52

pharmaphorum

APRIL 1, 2021

In the past couple of years, Turbine worked with a number of big pharma companies, including Bayer, and has also started building its own pipeline, including a target delivering new biological insight in PARP inhibitor resistance. “We That’s an area that we’re also looking at launching collaborations in.

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

pharmaphorum

JANUARY 4, 2022

Holmes and ex-Theranos chief operating officer – Ramesh ‘Sunny’ Balwani – were accused of using adverts and meetings to encourage doctors and patients to use its proprietary analyser and services, even though they knew they were incapable of producing reliable results for some tests. It eventually folded in 2018.

Pharma Companies 52

Pharma Companies Doctor Doctors Trials 52

XTalks

MAY 3, 2024

According to Real Chemistry, there are currently 119 active GLP-1 agonist clinical trials, with 53 in Phases III or IV, across more than 60 potential new indications for GLP-1 treatment.

Drugs 52

Drugs Clinical Trials Clinical Trials Marketing 52

pharmaphorum

MAY 25, 2022

Organisations are increasingly aware that the needs and priorities of patients, rather than their doctors, should be their driving force. Therefore, it is essential companies understand the clinical outcomes that are meaningful to patients, and the quality-of-life trade-offs people are willing to make to achieve those outcomes.”.

Development 98

Development Pharma Companies Production Doctor 98

pharmaphorum

JULY 9, 2021

Digital technologies are proving their value by allowing for better care, improved adherence and a more connected ecosystem between doctors, patients and pharma. And by joining up pharma and healthcare, these tools can create an ecosystem where the two sectors are working together to put the patient at the centre of care, he says.

Doctor 69

Doctor Doctors Marketing Development 69

Delveinsight

AUGUST 13, 2020

The contribution of key pharma companies, such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and Zedira is significant in driving Celiac disease market size. Who would have thought that consumption of gluten can trigger an autoimmune disorder?

Marketing 52

Marketing Trials Antibody Pharma Companies 52

Pharma Marketing Network

FEBRUARY 27, 2025

So, how can pharma companies use content marketing to engage HCPs and patients effectively ? Pharma brands can develop: Whitepapers on clinical trials showcasing drug effectiveness. Doctor-patient interviews on managing chronic conditions. Lets dive in. Case studies on patient outcomes using specific treatments.

Branding 52

Branding Marketing Compliance Pharma Companies 52

WCG Clinical

JUNE 4, 2024

Right now, you know, observational studies, as they’re called, or natural history studies, entail academic centers setting up sites, and then patients will go at an interval of three months or six months or a year depending on the disease and answer a set of questions that, a doctor or physician will will provide to them.

Research 52

Research Clinical Trials Clinical Trials Doctor 52

Pharma Marketing Network

JUNE 8, 2020

Don (PMN): Sure, yea patients need to be aware of their conditions and also be motivated to see their doctors for treatment right. I mean how many campaigns was I involved with, be it commercials or ads, like “Ask your doctor what’s right for you.” Do you connect patients with the clinical trial folks? Bob (83Bar): Yes, we do.

Doctor 40

Doctor Doctors Clinical Trials Clinical Trials 40

Pharma Marketing Network

DECEMBER 13, 2024

Omnichannel Integration: Seamlessly blending online and offline interactions ensures your message is consistent, whether a doctor sees your ad in a journal or on YouTube. Personalized Messaging Personalization is a game-changer in pharma advertising. How can pharma companies personalize their campaigns?

Marketing 52

Marketing Branding Compliance Engineer 52

The Pharma Data

NOVEMBER 27, 2020

This week, another pharma company revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose.

Vaccine 52

Vaccine Vaccination Immune Response Marketing 52

pharmaphorum

DECEMBER 21, 2021

Additionally, the work being done within Rare Disease networks, formed of specialty sites, pharma companies, CROs, researchers, and other stakeholders, can all benefit from the value generated by real world genomic data, as outlined by panellist Dr Joanne Hackett, Head of Genomic and Precision medicine at IQVIA.

Development 98

Development Genomics Genome Drugs 98

Intouch Solutions

APRIL 11, 2024

Clinical : Optimized efficiency, inventory management, and service quality of clinical trials. Commercial : Improved experience and communication between patients and doctors. Pre-Clinical : Deeper comprehension of the impacts and outcomes associated with a particular drug.

Compliance 52

Compliance Drugs Marketing Pharma Companies 52

Pharma Marketing Network

OCTOBER 27, 2020

It really gave me a different look at the healthcare system than I had from my mom being a doctor and so when I went into remission and I got off a lot of the medications and I’ve been feeling really good now for a couple of decades don’t try and do the math.

Insulin 52

Insulin Marketing Doctor Doctors 52

Pharma Marketing Network

OCTOBER 27, 2020

It really gave me a different look at the healthcare system than I had from my mom being a doctor and so when I went into remission and I got off a lot of the medications and I’ve been feeling really good now for a couple of decades don’t try and do the math.

Insulin 52

Insulin Doctor Doctors Marketing 52

World of DTC Marketing

AUGUST 9, 2021

HCPs don’t necessarily want pharma trying to sell products via social media. The best approach is to use social media to connect HCPs to clincial information and drug trials. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug.

Nurses 294

Nurses Marketing Pharma Companies Production 294

XTalks

OCTOBER 1, 2020

The drug is currently in clinical trials for alcoholic hepatitis (AH), nonalcoholic steatohepatitis (NASH), as well as in COVID-19 patients with acute liver or kidney injury. In the beginning, I always thought I wanted to be a doctor, but then I felt it was very depressing, particularly at that time and in that particular field.

Scientist 52

Scientist In-Vitro Research Life Science 52

World of DTC Marketing

JANUARY 31, 2021

The venture capitalists funding them are looking for a big payday when a pharma company acquires them. I have been recruited by these companies who promise huge payouts when they are acquired if their drug shows promise in clinical trials. In pharma R&D returns have declined to 1.8 percent from 2018.

In-Vivo 187

In-Vivo Generic Drugs Drugs Gene Therapy 187

pharmaphorum

AUGUST 9, 2022

The potential of the area has motivated an increasing number of companies to emerge in the space, with a greater number of collaborations occurring between these AI-specialists and big pharma companies. To develop this particular candidate, the company designed and eliminated 175 novel candidates. Patient focus.

Drugs 111

Drugs Doctor Doctors Pharma Companies 111